IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v14y2013i5p799-808.html
   My bibliography  Save this article

Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study

Author

Listed:
  • Sarah Mostardt
  • Nikola Hanhoff
  • Jürgen Wasem
  • Armin Goetzenich
  • Knud Schewe
  • Eva Wolf
  • Christoph Mayr
  • Hans Jaeger
  • Holger Pfaff
  • Stephan Dupke
  • Anja Neumann

Abstract

Expenditures for HIV-infection are driven mainly by drug costs. We identified several clinical variables influencing the costs of HIV-treatment. This information could assist policymakers when allocating limited health care resources to HIV care. Copyright Springer-Verlag 2013

Suggested Citation

  • Sarah Mostardt & Nikola Hanhoff & Jürgen Wasem & Armin Goetzenich & Knud Schewe & Eva Wolf & Christoph Mayr & Hans Jaeger & Holger Pfaff & Stephan Dupke & Anja Neumann, 2013. "Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(5), pages 799-808, October.
    • Handle: RePEc:spr:eujhec:v:14:y:2013:i:5:p:799-808
    DOI: 10.1007/s10198-012-0425-4
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10198-012-0425-4
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s10198-012-0425-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Koopmanschap, Marc A. & Touw, Karien C. R. & Rutten, Frans F. H., 2001. "Analysis of costs and cost-effectiveness in multinational trials," Health Policy, Elsevier, vol. 58(2), pages 175-186, November.
    2. Claes, Christa & Mittendorf, Thomas & Stoll, Matthias, 2009. "Versorgung von HIV-Patienten in Deutschland: Herausforderungen der Zukunft," Hannover Economic Papers (HEP) dp-424, Leibniz Universität Hannover, Wirtschaftswissenschaftliche Fakultät.
    3. Juan Oliva-Moreno & Julio López-Bastida & Pedro Serrano-Aguilar & Lilisbeth Perestelo-Pérez, 2010. "Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(4), pages 405-412, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Hege Urdahl & Andrea Manca & Mark Sculpher, 2006. "Assessing Generalisability in Model-Based Economic Evaluation Studies," PharmacoEconomics, Springer, vol. 24(12), pages 1181-1197, December.
    2. Tom Rom & Itzchak Levy & Saritte Perlman & Tomer Ziv-Baran & Orna Mor, 2022. "Determinants of Direct Costs of HIV-1 Outpatient Care in Israel," IJERPH, MDPI, vol. 19(21), pages 1-11, November.
    3. Sarah Wordsworth & Anne Ludbrook, 2005. "Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities," Health Economics, John Wiley & Sons, Ltd., vol. 14(1), pages 93-99, January.
    4. Nicolas A Menzies & Andres A Berruti & John M Blandford, 2012. "The Determinants of HIV Treatment Costs in Resource Limited Settings," PLOS ONE, Public Library of Science, vol. 7(11), pages 1-9, November.
    5. Sarah Wordsworth & Anne Ludbrook & Fergus Caskey & Alison Macleod, 2005. "Collecting unit cost data in multicentre studies," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 38-44, March.
    6. Tarricone, Rosanna, 2006. "Cost-of-illness analysis: What room in health economics?," Health Policy, Elsevier, vol. 77(1), pages 51-63, June.

    More about this item

    Keywords

    Cost of illness; HIV; AIDS; Germany; HAART; Ambulatory care; I15;
    All these keywords.

    JEL classification:

    • I15 - Health, Education, and Welfare - - Health - - - Health and Economic Development

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:14:y:2013:i:5:p:799-808. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.